Amiji,Mansoor

Institution: Northeastern University, USA

Top Collaborators: Kriegel C, Milane L, Ganta S, Duan Z, Ganesh S, Xu J, Jain S, Deshpande D, Duan ZF, Chadwick S, Elangovan S, Tsai PC, Margolis HC, Attarwala H, Gattacceca F, Korde A, Shah S, Dehelean CA, Feflea S, Gultepe E

Research Interests: Tumor, Therapeutic, Epidermal Growth Factor, Nanoparticles, Administration, Cancer, Cells, Drugs, Paclitaxel, Growth, Mice, Gene, Diseases, Efficiency, Human, Treatment, Blood, Cell, Tissue, Water

Publications
Grants
Speaking Events

Information and abstracts for author publications
Published Date	Impact	Publication
11/14/2009	11.5	Advanced drug delivery reviews Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices.	Abstract
12/07/2012	11.5	Advanced drug delivery reviews Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.	Abstract
11/18/2009	11.5	Advanced drug delivery reviews Nanotechnology solutions for mucosal immunization.	Abstract
04/08/2011	5.7	Journal of controlled release : official journal of the Controlled Release Society Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.	Abstract
10/17/2010	5.7	Journal of controlled release : official journal of the Controlled Release Society Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease.	Abstract
03/19/2012	5.5	Biomacromolecules Tuftsin-modified alginate nanoparticles as a noncondensing macrophage-targeted DNA delivery system.	Abstract
01/08/2011	5.1	Nanomedicine : nanotechnology, biology, and medicine Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer.	Abstract
03/07/2013	5.1	Nanomedicine : nanotechnology, biology, and medicine Engineering of an ω-3 polyunsaturated fatty acid-containing nanoemulsion system for combination C6-ceramide and 17β-estradiol delivery and bioactivity in human vascular endothelial and smooth muscle cells.	Abstract
04/16/2013	4.8	Molecular pharmaceutics Biodistribution and pharmacokinetics of EGFR-targeted thiolated gelatin nanoparticles following systemic administration in pancreatic tumor-bearing mice.	Abstract
06/03/2009	4.8	Molecular pharmaceutics Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.	Abstract
11/24/2010	4.8	Molecular pharmaceutics Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells.	Abstract
06/27/2011	4.2	Journal of biomedical nanotechnology Anti-angiogenic effects of betulinic acid administered in nanoemulsion formulation using chorioallantoic membrane assay.	Abstract
09/08/2011	4.1	PloS one Therapeutic efficacy and safety of paclitaxel/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer.	Abstract
04/06/2009	3.5	Expert opinion on biological therapy Delivery strategies to enhance mucosal vaccination.	Abstract
05/19/2011	3.4	International journal of pharmaceutics Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery.	Abstract
09/16/2010	3.1	Journal of pharmaceutical sciences Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation.	Abstract
10/07/2010	2.9	Molecular membrane biology A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers.	Abstract
03/13/2012	2.6	Journal of periodontology Nano-sized calcium phosphate particles for periodontal gene therapy.	Abstract

Grants Recieved by this author
Budget Start	Budget End	Grant Type	Project Cost	Project Title
7/01/2010	6/30/2015	NSF Standard Grant	$3,038,704	IGERT Nanomedicine Science and Technology
9/01/2010	7/31/2014	NIH U01: Research Project--Cooperative Agreements	$1,695,677	COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE
9/01/2010	7/31/2014	NIH U54: Specialized Center--Cooperative Agreements	$761,977	Multi-Modal Gene Therapy for Pancreatic Cancer using Targeted Nanovectors
9/01/2010	7/31/2014	NIH U54: Specialized Center--Cooperative Agreements	$220,241	Education/Training and Outreach Activites
4/01/2011	3/31/2014	NIH R01: Research Project	$1,705,467	Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer
2/15/2010	4/30/2013	NIH R21: Exploratory/Developmental Grants	$429,000	Multifunctional Nanoemulsions for Modulation of BBB Transport
3/01/2008	2/28/2013	NIH R01: Research Project	$1,324,524	ORAL GENE THERAPY WITH NiMOS FOR INFLAMMATORY BOWEL DISEASE
1/01/2010	12/31/2012	NIH R21: Exploratory/Developmental Grants	$366,263	NANO-DELIVERY OF MITOCHONDRIA-SPECIFIC CERAMIDE TO OVERCOME TUMOR DRUG RESISTANCE
8/01/2007	8/31/2011	NIH R01: Research Project	$922,177	NANOTHERAPEUTIC STRATEGY FOR MULTIDRUG RESISTANT TUMORS

Conferences the author is attending
Title	Description
Applied Pharmaceutical Nanotechnology 2017	The Applied Pharmaceutical Nanotechnology conference is a forum for exchanging information, generating ideas and discussing strategies focused on industry-specific applications of nanomaterials, their…

Amiji,Mansoor

Related JoVE Videos